| Autor: |
Heimovaara, Joosje H., Huis in 't Veld, Evangeline A., Lok, Christianne A. R., Garcia, Alvaro Cabrera, Halaska, Michael J., Boere, Ingrid, Gziri, Mina Mhallem, Fruscio, Robert, Painter, Rebecca C., Cardonick, Elyce, van den Heuvel‐Eibrink, Marry M., Masturzo, B., Van Calsteren, Kristel, van Zuylen, Lia, Amant, Frederic |
| Zdroj: |
BJOG: An International Journal of Obstetrics & Gynaecology; Nov2024, Vol. 131 Issue 12, p1694-1704, 11p |
| Abstrakt: |
Objective: To characterise pregnant women diagnosed with primary or recurrent cancer who died during pregnancy, during delivery or within 1 year postpartum. Design: A descriptive study. Setting: The registry of the International Network on Cancer, Infertility and Pregnancy (INCIP). Population: Women diagnosed with cancer during pregnancy between 2000 and 2022. Methods: Using the INCIP registry database, we compared the characteristics of all women with cancer who died during pregnancy, delivery or within 1 year postpartum with those of all women with cancer who survived the first year postpartum. Main Outcome Measures: Maternal and tumour characteristics and obstetrical and neonatal outcomes. Results: Of the 2359 women registered in INCIP, there were 131 cases (5.6%) of maternal mortality. Lung cancer (9/14, 64.3% of all registered women with lung cancer), gastro‐oesophageal cancer (13/21, 61.9%) and acute leukaemia (17/105, 16.2%) had the highest rates of maternal mortality. Maternal mortality was associated with fewer live births compared with the control group without maternal mortality (99/131, 75.6%, vs 1952/2163, 90.0%; P < 0.001), more elective caesarean sections (64/104, 60.4%, vs 756/1836, 41.2%; P < 0.001) and a lower gestational age at (induced) delivery (34.0 vs 37.1 weeks; P < 0.001), resulting in more preterm births. Conclusions: Maternal mortality occurred in 5.6% of cancer‐in‐pregnancy cases and is associated with adverse perinatal outcomes. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text